ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA

Lu, Li; Cai, Yanzhen; Luo, Xiaoling; Wang, Zhangting; Fung, Sin Hang; Jia, Huanhuan; Yu, Chi Lam; Chan, Wai Yee; Miu, Kai Kei*; Xiao, Wende*广东药学院; 1
Frontiers in Pharmacology2021-11-24DOI: 10.3389/fphar.2021.750959
17阅读
引用收藏
分享

摘要

Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study, we argue that the susceptibility to epigenetic changes governing molecular cross talks along the BMP and PI3K/Akt pathway may underline how genetic background dictate GC-induced bone loss. Concordantly, osteoblasts from BALB/c or C57BL/6 neonatal mice were treated with dexamethasone for transcriptome profiling. Furthermore, we also confirmed that GC-pre-conditioned mesenchymal stem cells (MSCs) would give rise to defective osteogenesis by instigating epigenetic changes which affected the accessibility of enhancer marks. In line with these epigenetic changes, we propose that GC modulates a key regulatory network involving the scavenger receptor Cd36 in osteoblasts pre-conditioning pharmacological idiosyncrasy in GIO.

学科与关键词

关键词
glucocorticoidglucocorticoid-induced osteoporosisbone lossbone morphogenetic protein signaling pathwayosteoblasts differentiationcis-expression quantitative trait loci
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-11-24
卷期
第 12 卷
页码
750959
DOI
10.3389/fphar.2021.750959
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
NSFC/RGC Joint Research Scheme - Research Grants Council of the Hong Kong Special Administrative Region, China; National Natural Science Foundation of China [N_CUHK415/16]; Guangzhou Science and Technology Project of China [201904010053]; Research Grants Council General Research Fund, Hong Kong [14103418]; Health and Medical Research Fund, Hong Kong [06170996]

作者

  • L

    Lu, Li (第一作者)

    guangdong pharmaceut univ

  • C

    Cai, Yanzhen

    guangdong pharmaceut univ

查看全部 10 位作者收起作者
  • L

    Luo, Xiaoling

    guangdong pharmaceut univ

  • W

    Wang, Zhangting

    chinese univ hong kong

  • F

    Fung, Sin Hang

    chinese univ hong kong

  • J

    Jia, Huanhuan

    guangdong lab anim monitoring inst · guangdong pharmaceut univ

  • Y

    Yu, Chi Lam

    chinese univ hong kong

  • C

    Chan, Wai Yee

    chinese univ hong kong

  • M

    Miu, Kai Kei (通讯)

    chinese univ hong kong

  • X

    Xiao, Wende (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417